---
figid: PMC9274053__jgo-13-03-1444-f5
pmcid: PMC9274053
image_filename: jgo-13-03-1444-f5.jpg
figure_link: /pmc/articles/PMC9274053/figure/f5/
number: Figure 5
figure_title: ''
caption: UBE2C influences the glycolytic activity of PC cells. (A,B) Glucose uptake,
  lactate production, and ATP generation were analyzed in PC cells following shNT
  or shUBE2C treatment. (C,D) Glucose uptake rates, lactate production, and ATP generation
  were assessed in PC cells following shNT or shEGFR treatment. *, P<0.05; ***, P<0.001.
  UBE2C, ubiquitin-conjugating enzyme E2C; PC, pancreatic cancer.
article_title: UBE2C promotes the progression of pancreatic cancer and glycolytic
  activity via EGFR stabilization-mediated PI3K-Akt pathway activation.
citation: Jing-Zhu Cao, et al. J Gastrointest Oncol. 2022 Jun;13(3):1444-1453.
year: '2022'

doi: 10.21037/jgo-22-516
journal_title: Journal of Gastrointestinal Oncology
journal_nlm_ta: J Gastrointest Oncol
publisher_name: AME Publishing Company

keywords:
- Epidermal growth factor receptor (EGFR)
- pancreatic cancer (PC)
- metastasis
- PI3K-Akt
- ubiquitin-conjugating enzyme E2C (UBE2C)

---
